Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma
暂无分享,去创建一个
[1] T. Cloughesy,et al. Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids , 2020, iScience.
[2] J. Hsieh,et al. Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma , 2020, Cell Death & Disease.
[3] Wei Zheng,et al. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma , 2020, Oncology letters.
[4] S-Y Wang,et al. LncRNA SNHG7 enhances chemoresistance in neuroblastoma through cisplatin-induced autophagy by regulating miR-329-3p/MYO10 axis. , 2020, European review for medical and pharmacological sciences.
[5] A. D. Tangutur,et al. Inhibition of JNJ-26481585-mediated autophagy induces apoptosis via ROS activation and mitochondrial membrane potential disruption in neuroblastoma cells , 2020, Molecular and Cellular Biochemistry.
[6] Zhen-hua Hu,et al. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway , 2019, Cell cycle.
[7] Ji-cheng Tantai,et al. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7 , 2019, Cell Death & Disease.
[8] Yuan Cheng,et al. Targeting the Mitotic Catastrophe Signaling Pathway in Cancer , 2015, Mediators of inflammation.
[9] J. Klaunig. Oxidative Stress and Cancer. , 2019, Current pharmaceutical design.
[10] C. James,et al. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy , 2019, Autophagy.
[11] Gong Yang,et al. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy , 2019, Theranostics.
[12] Xiaokun Lin,et al. Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells , 2018, Bioscience reports.
[13] Yu Liu,et al. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer , 2018, Theranostics.
[14] Matthew A. Taylor,et al. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma , 2018, Apoptosis.
[15] Xingdong Zhou,et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion , 2018, Autophagy.
[16] J. Kraveka,et al. Updates in Diagnosis, Management, and Treatment of Neuroblastoma. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.
[17] A. Tamimi,et al. Epidemiology and Outcome of Glioblastoma , 2017 .
[18] A. Thorburn,et al. Targeting autophagy in cancer , 2017, Nature Reviews Cancer.
[19] M. Kashyap,et al. Autophagy Activation Alleviates Amyloid-β-Induced Oxidative Stress, Apoptosis and Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells , 2017, Neurotoxicity Research.
[20] T. Hudlický,et al. Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III , 2017, Scientific Reports.
[21] Xiaoyan Wang,et al. Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE−/− mice by modulating autophagy, foam cell formation and immune-negative molecules , 2016, Cell Death & Disease.
[22] E. Haddad,et al. Autophagy is associated with chemoresistance in neuroblastoma , 2016, BMC Cancer.
[23] M. Davis. Glioblastoma: Overview of Disease and Treatment. , 2016, Clinical journal of oncology nursing.
[24] E. White,et al. Mitochondria and Cancer. , 2016, Molecular cell.
[25] P. Lam,et al. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status , 2015, BMC Cancer.
[26] K. Tamura,et al. [Side effects of chemotherapy]. , 2015, Nihon rinsho. Japanese journal of clinical medicine.
[27] Thomas C. Chen,et al. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. , 2014, Neurosurgical focus.
[28] Jill S. Barnholtz-Sloan,et al. Epidemiologic and Molecular Prognostic Review of Glioblastoma , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[29] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[30] Z. Huang,et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment , 2013, Cell Death and Disease.
[31] P. Bischoff,et al. The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line. , 2013, Anticancer research.
[32] F. Sinicrope,et al. The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.
[33] F. Sinicrope,et al. Autophagy modulation for cancer therapy , 2011, Cancer biology & therapy.
[34] Sandra Barth,et al. Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.
[35] H. Caron,et al. Neuroblastoma: biology, prognosis, and treatment. , 2010, Hematology/oncology clinics of North America.
[36] B. Hero,et al. Neuroblastoma , 2007, The Lancet.
[37] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[38] I. Germano,et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells , 2004, Cell Death and Differentiation.
[39] P. Seglen,et al. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Weller,et al. Chapter 23 - Glioblastoma , 2016 .
[41] M. Stevens,et al. Temozolomide: mechanisms of action, repair and resistance. , 2012, Current molecular pharmacology.
[42] D. Rubinsztein,et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies , 2009, Cell Death and Differentiation.
[43] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.